Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kushwin, Rajamani"'
Autor:
Dennis H. Lau, Tina Lin, Sam Lovibond, Andre Conradie, Uwais Mohamed, Jürgen Schrader, Stephen Pavia, Peter Illes, Ian Matthews, Justin A. Mariani, Rajeev Kumar Pathak, Paul A. Gould, David DiFiore, Rukshen Weerasooriya, Deepak Arumugam, Olivier W V van den Brink, Kushwin Rajamani
Publikováno v:
Journal of Electrocardiology. 60:118-125
Background Implantable Cardiac Monitors (ICMs) are used for long-term monitoring of arrhythmias. BIOMONITOR III is a novel ICM with a miniaturized profile, long sensing vector due to a flexible antenna, simplified implantation with a dedicated insert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52456e23923cd176ba7a15ee48426e98
https://doi.org/10.1016/j.jelectrocard.2020.04.004
https://doi.org/10.1016/j.jelectrocard.2020.04.004
Autor:
Joanne T.M. Tan, Laura Lecce, Yuen Ting Lam, Anthony C Keech, Jun Yuan, Alicia J. Jenkins, Emma L. Solly, Martin K.C. Ng, Kushwin Rajamani, Christina A. Bursill, Philippa J. L. Simpson, E. King
Publikováno v:
Diabetes. 68:1040-1053
Fenofibrate, a peroxisome proliferator–activated receptor α (PPARα) agonist, reduces lower limb amputations in patients with type 2 diabetes. The mechanism is, however, unknown. In this study, we demonstrate that fenofibrate markedly attenuates d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c844616ee903136bb76fa3abf8ec1c0a
https://doi.org/10.2337/db17-0926
https://doi.org/10.2337/db17-0926
Autor:
Kushwin Rajamani, Patrick Tchou
Publikováno v:
Handbook of Cardiac Electrophysiology ISBN: 9781315118086
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb1f1ff58609272cd542ea7320149c22
https://doi.org/10.1201/9781315118086-28
https://doi.org/10.1201/9781315118086-28
Publikováno v:
Handbook of Cardiac Electrophysiology ISBN: 9781315118086
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7352ebbf1895c1888c4687176ef17bfd
https://doi.org/10.1201/9781315118086-20
https://doi.org/10.1201/9781315118086-20
Publikováno v:
Handbook of Cardiac Electrophysiology ISBN: 9781315118086
This chapter discusses implantation of pacemakers and implantable cardioverter-defibrillators (ICDs). Patients must have an indication for pacemaker or implantable cardioverter-defibrillator (ICD) according to ACC/AHA guidelines. Once patients are in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e192b92a5ce47b89834e93a15da5bdb
https://doi.org/10.1201/9781315118086-19
https://doi.org/10.1201/9781315118086-19
Autor:
John Richard Baker, Anthony C Keech, Michael C d'Emden, Li Ping Li, Merryn Voysey, Peter G. Colman, James D. Best, Kushwin Rajamani, Markku Laakso
Publikováno v:
The Lancet. 373:1780-1788
BACKGROUND: Amputations in people with type 2 diabetes mellitus substantially impair their quality of life and impose high costs on health-care systems. Our aim was to assess the effect of fenofibrate on amputation events in a large cohort of patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e50ee87ac026aea9b7da128f5aee87
https://doi.org/10.1016/s0140-6736(09)60698-x
https://doi.org/10.1016/s0140-6736(09)60698-x
Publikováno v:
Circulation. 130
Background: Fenofibrate, a PPARα agonist, reduced amputation events in the Fenofibrate Intervention and Event Lowering in Diabetes study among 9795 patients, the mechanisms of which are unknown. We hypothesised that fenofibrate may attenuate diabete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8596e3c7ffe3ff4e0cd05dd06fecaff5
https://doi.org/10.1161/circ.130.suppl_2.14774
https://doi.org/10.1161/circ.130.suppl_2.14774
Publikováno v:
Cardiology clinics. 32(2)
Patients who receive shock therapy have an associated reduction in the mortality benefit from implantable cardioverter defibrillators (ICDs). Prolonging the time to therapy and restricting therapy to faster tachycardias can significantly reduce shock
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5249f81d711fc5a74318ce3503aa40b
https://pubmed.ncbi.nlm.nih.gov/24793796
https://pubmed.ncbi.nlm.nih.gov/24793796
Publikováno v:
European Journal of Pharmacology. 423:223-228
Methylenedioxymethamphetamine (MDMA, 'ecstasy') has major agonist actions at prejunctional alpha(2A/D)-adrenoceptors in the rat. We wished to establish whether MDMA has potency at more than one subtype of alpha(2)-adrenoceptor, in line with affinity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e32b6addaa1510aa1c5f3bcdff22c98e
https://doi.org/10.1016/s0014-2999(01)01118-9
https://doi.org/10.1016/s0014-2999(01)01118-9
Autor:
Ru-Dee, Ting, Anthony C, Keech, Paul L, Drury, Mark W, Donoghoe, John, Hedley, Alicia J, Jenkins, Timothy M E, Davis, Seppo, Lehto, David, Celermajer, R John, Simes, Kushwin, Rajamani, Kim, Stanton, R, Scott
Publikováno v:
Diabetes Care
OBJECTIVE Diabetic patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] 30–59 mL/min/1.73 m2) are at particular cardiovascular risk. Fenofibrate’s safety in these patients is an issue because it may elevate plasma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3df632e14bb4e460a6ffde2839a93ebe
https://pubmed.ncbi.nlm.nih.gov/22210576
https://pubmed.ncbi.nlm.nih.gov/22210576